Lexicon Pharmaceuticals (LXRX) Stock Heats up on Citi Upgrade
Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) stock is making a run in the market this morning, but with no press releases or SEC filings, the big question is, “Why?” The gains are ultimately the result of an upgrade. Then again, we’re talking about gains of more than 60%. What is it about this analyst upgrade and … Read more